| 740 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Study Shows Flu Vaccination Prevents Significant Flu Illness, Doctor's Visits and Hospitalizations |
CDC Study Shows Flu Vaccination Prevents Significant Flu Illness, Doctor’s Visits and Hospitalizations |
| significant vaccine benefits | 0.323604 |
| CDC experts | 0.353985 |
| lowest number | 0.265292 |
| flu vaccines | 0.503655 |
| flu vaccination program | 0.700541 |
| flu vaccination | 0.940979 |
| observational studies | 0.270628 |
| U.S. flu vaccination | 0.572756 |
| fewer flu cases | 0.489268 |
| non-elderly adults | 0.263224 |
| new CDC model | 0.332142 |
| substantial health benefits | 0.311512 |
| 6-year period | 0.278639 |
| flu surveillance data | 0.521448 |
| flu-associated disease outcomes | 0.316504 |
| specific times | 0.267689 |
| possible reason | 0.263865 |
| age groups | 0.313815 |
| vaccine effectiveness | 0.274609 |
| medical visits | 0.395556 |
| H1N1 pandemic | 0.268253 |
| 2009 pandemic | 0.266679 |
| direct annual impact | 0.327989 |
| new model | 0.333586 |
| health benefits | 0.321126 |
|
| Better flu vaccines | 0.490337 |
| study | 0.274439 |
| United States | 0.595935 |
| flu-related medical visits | 0.346171 |
| specific populations | 0.266655 |
| flu vaccination coverage | 0.567414 |
| burden | 0.270875 |
| flu-related hospitalizations | 0.440218 |
| 2010-11 season | 0.269005 |
| potential flu cases | 0.502186 |
| public health benefit | 0.319181 |
| repeatable way | 0.271696 |
| annual flu vaccination | 0.649293 |
| public health | 0.329863 |
| effective flu vaccines | 0.480513 |
| CDC researchers | 0.282534 |
| flu cases | 0.697843 |
| vaccine coverage | 0.326006 |
| study authors | 0.263408 |
| greatest benefit | 0.262534 |
| milder flu activity | 0.492889 |
| public health benefits | 0.318482 |
| higher public awareness | 0.314555 |
| disproportionately large portion | 0.316476 |
|
CLICK HERE |
| 4453 |
Centers for Disease Control and Prevention |
Html |
en |
Stay Safe on the Water: National Safe Boating Week | CDC Features |
Wearing a life jacket can dramatically decrease your chances of drowning while boating. Learn more during National Safe Boating Week, May 21-27, 2011, and |
| properly-fitted life jackets | 0.65474 |
| Carbon Monoxide Poisoning | 0.592909 |
| safe operation | 0.449322 |
| local requirements | 0.444614 |
| free public service | 0.564253 |
| poisonous gas | 0.440632 |
| influence | 0.342599 |
| PFD | 0.338094 |
| VSC Program | 0.467215 |
| sufficient ventilation | 0.439425 |
| boat engines | 0.458382 |
| Power Squadron volunteer | 0.560029 |
| boat operators | 0.472196 |
| alcohol | 0.445788 |
| greater risk | 0.452432 |
| passengers | 0.384795 |
| seasickness | 0.335904 |
| CDC Resources | 0.450473 |
| web site | 0.581997 |
| carbon monoxide | 0.715711 |
| recreational boating fatalities | 0.775713 |
| drownings | 0.337802 |
| water | 0.349429 |
| drink | 0.333824 |
| internal combustion engines | 0.554665 |
|
| Vessel Safety Check | 0.75227 |
| child injury | 0.474006 |
| fitted life jackets | 0.62269 |
| education courses | 0.445815 |
| wonderful way | 0.459412 |
| parents | 0.353286 |
| United States | 0.621762 |
| operator error | 0.438054 |
| early stages | 0.434931 |
| Administrators Web site | 0.556754 |
| Guard-approved life jackets | 0.632037 |
| fatal boating incidents | 0.782039 |
| State Boating Law | 0.727073 |
| recreational boats | 0.444124 |
| life jackets | 0.910724 |
| personal flotation devices | 0.619845 |
| people | 0.37121 |
| National Association | 0.444453 |
| following resources | 0.439534 |
| motor generators | 0.436227 |
| External Resources | 0.443471 |
| U.S. Coast Guard | 0.555348 |
| stays fun | 0.463504 |
| life-saving role | 0.482264 |
|
CLICK HERE |
| 6724 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables - January 21, 2011 / 60(02);48-61 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| H. influenzae | 0.286293 |
| novel influenza | 0.611589 |
| pandemic influenza | 0.932075 |
| Influenza Division | 0.406694 |
| dengue shock syndrome | 0.394085 |
| 2009 pandemic | 0.650737 |
|
| probable cases | 0.229697 |
| Respiratory Diseases | 0.20367 |
| severe form | 0.20524 |
| human infection | 0.233506 |
| ** Data | 0.2422 |
| influenza A virus | 0.484809 |
|
CLICK HERE |
| 7290 |
Centers for Disease Control and Prevention |
Html |
en |
Fact Sheets - Physical Activity |
Physical Activity factsheets. |
| future service members | 0.803634 |
| Active People | 0.636435 |
| CDC | 0.456161 |
| goal | 0.443624 |
| Healthy Nation | 0.680597 |
| lives | 0.443505 |
| Builds | 0.440317 |
| better health | 0.589758 |
| effects obesity | 0.629006 |
| Americans | 0.50942 |
|
| healthy eating | 0.657362 |
| Better HealthFind | 0.607019 |
| economy | 0.441856 |
| Strong AmericaThis | 0.612289 |
| physical activity | 0.994679 |
| national initiative | 0.649362 |
| community benefits | 0.602386 |
| PDF-1.37MB] | 0.659103 |
| performance benefits | 0.612628 |
| military readiness | 0.822582 |
|
CLICK HERE |
| 7896 |
Centers for Disease Control and Prevention |
Html |
en |
Erratum: Vol. 61, No. 47 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.803406 |
| paragraph | 0.631544 |
| Puerto Rico | 0.782599 |
| endorsement | 0.705737 |
| U.S. Government Printing | 0.908687 |
| Human Services | 0.939472 |
| Relatives Employed | 0.792798 |
| assistive technology | 0.811679 |
| Superintendent | 0.635474 |
| U.S. Environmental Protection | 0.948472 |
| Battery Recycling Facility | 0.941419 |
| assistance | 0.631936 |
| title | 0.629977 |
| percent | 0.635297 |
| U.S. Department | 0.933711 |
| MMWR HTML versions | 0.925116 |
| MMWR readers | 0.788338 |
| character translation | 0.767259 |
| concern | 0.629908 |
| file | 0.632183 |
| identification | 0.628396 |
| MMWR paper copy | 0.919456 |
| electronic PDF version | 0.905804 |
| Persons | 0.632331 |
|
| e-mail | 0.659589 |
| Children | 0.629577 |
| ТЕg/ft2 | 0.628749 |
| vehicle dust samples | 0.948575 |
| format errors | 0.777889 |
| sentence | 0.692002 |
| subject line | 0.789196 |
| Health | 0.65399 |
| level | 0.628798 |
| Contact GPO | 0.821638 |
| typeset documents | 0.784424 |
| trade names | 0.780005 |
| commercial sources | 0.77982 |
| official text | 0.764294 |
| current prices | 0.768369 |
| non-CDC sites | 0.778013 |
| original paper copy | 0.905205 |
| report | 0.657478 |
| home dust samples | 0.94775 |
| information | 0.632214 |
| Accommodation | 0.630007 |
| page | 0.62938 |
| electronic conversions | 0.768701 |
|
CLICK HERE |
| 8222 |
Centers for Disease Control and Prevention |
Html |
en |
Spina Bifida, Facts - NCBDDD - CDC |
Spina bifida is a condition that affects the spine and is usually apparent at birth. It is a type of neural tube defect (NTD). |
| spina bifida | 0.978795 |
| early pregnancy | 0.337138 |
| Treatments page | 0.319416 |
| productive lives | 0.31951 |
| neural tube | 0.383499 |
| neural tube defects | 0.334933 |
| type | 0.346163 |
| small sample | 0.320023 |
| common types | 0.322824 |
| small gap | 0.320521 |
| triple screen | 0.320605 |
| AFP – AFP | 0.334162 |
| pregnancy | 0.346789 |
| image scan | 0.32002 |
| spina bifida lead | 0.452469 |
| clear pictures | 0.319741 |
| myelomeningocele | 0.319136 |
| severe disabilities | 0.320549 |
| prenatal tests | 0.319862 |
| average levels | 0.32024 |
| simple blood test | 0.337753 |
| unborn baby | 0.324057 |
| high level | 0.342209 |
| minor disabilities | 0.320304 |
| late childhood | 0.338333 |
|
| United States | 0.320137 |
| hot tub | 0.319445 |
| AFP | 0.334632 |
| amniotic fluid | 0.319849 |
| neural tube defect | 0.341209 |
| intellectual disabilities | 0.323088 |
| sac | 0.327185 |
| store brand acetaminophen | 0.335624 |
| AFP test | 0.326721 |
| spinal cord | 0.412506 |
| folic acid | 0.38822 |
| nerve damage | 0.320852 |
| medical condition―such | 0.3197 |
| folic acid daily | 0.33939 |
| hairy patch | 0.319843 |
| spine | 0.325036 |
| prenatal testing | 0.320584 |
| people | 0.33755 |
| birth defects | 0.319629 |
| doctor | 0.327958 |
| healthy pregnancy | 0.319636 |
| spina bifida occulta | 0.584647 |
| baby | 0.393615 |
| mildest type | 0.322728 |
|
CLICK HERE |
| 9630 |
Centers for Disease Control and Prevention |
Html |
en |
Asthma - BRFSS 2008 - Child Asthma Data - Table L2.1 |
BRFSS 2008 - Child Asthma Data - Table L2.1 |
| HI | 0.409747 |
| Puerto Rico | 0.66204 |
| TX | 0.398701 |
| data | 0.391134 |
| NV | 0.399015 |
| CI denotes confidence | 0.930783 |
| NY | 0.402891 |
| Total ** | 0.736875 |
| states | 0.391073 |
| 22.4 | 0.412232 |
| WI | 0.391698 |
| 22.2 | 0.538228 |
| MD | 0.409642 |
| small sample size | 0.898347 |
| GA | 0.409007 |
| sample size | 0.96767 |
| CA | 0.423411 |
| binomial distribution | 0.669427 |
| WV | 0.393742 |
| MO | 0.401763 |
| WY | 0.395904 |
| IL | 0.406646 |
|
| MS | 0.40778 |
| normal approximation | 0.662327 |
| MT | 0.400283 |
| KS | 0.405825 |
| standard error | 0.665418 |
| Territories | 0.391729 |
| KY | 0.406446 |
| 10.6 | 0.518212 |
| 14.1 | 0.502016 |
| CT | 0.413991 |
| PA | 0.397892 |
| Columbia | 0.390971 |
| NE | 0.402983 |
| AZ | 0.416147 |
| confidence interval | 0.977792 |
| NH | 0.400805 |
| NJ | 0.395894 |
| 14.5 | 0.409135 |
| District | 0.391012 |
| VT | 0.395333 |
| DC | 0.42206 |
|
CLICK HERE |
| 13102 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis |
Guidance for follow-up and antiviral chemoprophylaxis of close contacts of cases of human infection with novel influenza A viruses associated with severe human disease, including H7N9 and HPAI H5N1. - CDC |
| avian influenza | 0.71971 |
| probable case | 0.369592 |
| influenza treatment | 0.36188 |
| limited non-sustained person-to-person | 0.35146 |
| novel influenza | 0.906777 |
| infection control | 0.307052 |
| non-sustained person-to-person transmission | 0.349043 |
| severe influenza | 0.372659 |
| inhaled zanamivir | 0.319158 |
| interim guidance | 0.335585 |
| exposure groups | 0.314801 |
| pandemic influenza | 0.347443 |
| oral oseltamivir | 0.316642 |
| probable novel influenza | 0.448353 |
| respiratory symptoms | 0.364611 |
| CDC’s Influenza | 0.359324 |
| human H5N1 virus | 0.33062 |
| pathogenic avian influenza | 0.373609 |
| probable cases | 0.319237 |
| CDC Influenza Division | 0.41004 |
| close contact | 0.390878 |
| Influenza Season | 0.360752 |
| influenza A virus | 0.5604 |
|
| New England journal | 0.448636 |
| Influenza Antiviral Medications | 0.436207 |
| World Health Organization | 0.320074 |
| H5N1 viruses | 0.307459 |
| seasonal influenza | 0.400431 |
| severe human disease | 0.494158 |
| acute uncomplicated influenza | 0.423076 |
| H5N1 case definitions | 0.344737 |
| virus infection | 0.478944 |
| antiviral chemoprophylaxis | 0.367805 |
| symptomatic H5N1 patient | 0.301832 |
| avian influenza home | 0.396145 |
| oseltamivir-resistant influenza | 0.34711 |
| human infections | 0.342757 |
| H7N9 virus | 0.310325 |
| seasonal influenza studies | 0.397509 |
| et al | 0.456578 |
| close contacts | 0.428221 |
| Avian Influenza AV | 0.373017 |
| H5N1 influenza morbidity | 0.412151 |
| influenza a viruses | 0.478027 |
| H5N1 virus infection | 0.378089 |
| human infection | 0.404497 |
|
CLICK HERE |
| 13907 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs: Increased Medicaid Prescriptions forPreexposure Prophylaxis Against HIV infection - New York,2012-2015 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
| NYSDOH Medicaid data | 0.316008 |
| black recipients | 0.277841 |
| York State Department | 0.42827 |
| Medicaid Policy | 0.276012 |
| potential prescribers | 0.274859 |
| New York City | 0.338467 |
| number | 0.306121 |
| HIV infections | 0.318433 |
| task force | 0.28838 |
| state health departments | 0.292944 |
| York state Medicaid | 0.368556 |
| AIDS Institute | 0.35399 |
| Medicaid program | 0.355746 |
| HIV-negative Medicaid recipients | 0.469945 |
| Franklin N. Laufer | 0.323056 |
| integrated PrEP | 0.384318 |
| Preexposure Prophylaxis | 0.27668 |
| 3-year period | 0.28759 |
| postexposure prophylaxis | 0.279542 |
| new york state | 0.941886 |
| persons | 0.324681 |
| PrEP prescribers | 0.383637 |
| human immunodeficiency virus | 0.327865 |
| Medicaid recipients | 0.696695 |
|
| high-risk HIV-negative Medicaid | 0.319099 |
| HIV care settings | 0.296437 |
| Prevent HIV Transmission | 0.288092 |
| PrEP toolkit | 0.379268 |
| Daily HIV preexposure | 0.305604 |
| health department efforts | 0.279164 |
| state Medicaid agency | 0.340302 |
| Medicaid Prescriptions | 0.313015 |
| immunodeficiency syndrome | 0.273002 |
| Public Health Practice | 0.273294 |
| HIV prevention strategy | 0.294907 |
| PrEP coverage | 0.368816 |
| AIDS Epidemic initiative | 0.435086 |
| PrEP regimen | 0.36461 |
| PrEP strategic plan | 0.398364 |
| Medicaid fee-for-service claims | 0.307759 |
| PrEP | 0.869176 |
| Medicaid data warehouse | 0.345231 |
| comprehensive health care | 0.273803 |
| PrEP provider FAQ | 0.406 |
| York City Department | 0.277756 |
| HIV prevention interventions | 0.285504 |
| potential users | 0.331162 |
| high-risk HIV-negative persons | 0.282225 |
|
CLICK HERE |
| 14618 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for Interpretation of Zika Virus AntibodyTest Results | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| flavivirus infection | 0.318859 |
| IgM antibody result | 0.3147 |
| Zika virus | 0.931279 |
| recent flavivirus infection | 0.315868 |
| Zika virus–specific IgM | 0.316171 |
| recent Zika virus | 0.470597 |
| pregnant women | 0.313812 |
| virus neuroinvasive disease | 0.323613 |
| anti-Zika virus IgM | 0.365682 |
| plaque reduction neutralization | 0.329373 |
| flavivirus | 0.321141 |
| Zika virus exposure | 0.33347 |
| dengue virus | 0.502612 |
| dengue virus infections | 0.387717 |
| ongoing Zika virus | 0.334996 |
| possible adverse pregnancy | 0.322783 |
| Zika virus disease | 0.533883 |
| negative rRT-PCR result | 0.316502 |
| virus IgM ELISA | 0.36597 |
| virus IgM antibodies | 0.423574 |
| igm antibody | 0.413656 |
| reduction neutralization test | 0.326376 |
| transcription–polymerase chain reaction | 0.331239 |
| single-stranded RNA virus | 0.325803 |
|
| reverse transcription–polymerase chain | 0.330844 |
| Zika virus transmission | 0.350261 |
| specific infecting virus | 0.415427 |
| illness onset | 0.334648 |
| clinically suspected dengue | 0.357907 |
| adverse pregnancy outcomes | 0.32318 |
| real-time reverse transcription–polymerase | 0.33085 |
| Zika virus infection | 0.792943 |
| serum IgM antibody | 0.313091 |
| Zika IgM Antibody | 0.335074 |
| anti-Zika virus antibodies | 0.390024 |
| additional recent Zika | 0.313712 |
| dengue virus share | 0.359421 |
| Zika virus antibody | 0.409964 |
| virus IgM antibody | 0.380936 |
| Zika virus infections | 0.39756 |
| dengue virus infection | 0.369299 |
| dengue virus testing | 0.368053 |
| negative IgM antibody | 0.349748 |
| Zika virus IgM | 0.424965 |
| West Nile virus | 0.341482 |
| enzyme-linked immunosorbent assay | 0.323383 |
| Zika virus pregnancy | 0.358152 |
| local Zika virus | 0.336506 |
|
CLICK HERE |